While the global integration of artificial intelligence (AI) into veterinary medicine is accelerating, its adoption dynamics in major markets such as China remain uncharacterized. This paper presents the first exploratory analysis of AI perception and adoption among veterinary professionals in China, based on a cross-sectional survey of 455 practitioners conducted in mid-2025. We identify a distinct "adoption paradox": although 71.0% of respondents have incorporated AI into their workflows, 44.6% of these active users report low familiarity with the technology. In contrast to the administrative-focused patterns observed in North America, adoption in China is practitioner-driven and centers on core clinical tasks, such as disease diagnosis (50.1%) and prescription calculation (44.8%). However, concerns regarding reliability and accuracy remain the primary barrier (54.3%), coexisting with a strong consensus (93.8%) for regulatory oversight. These findings suggest a unique "inside-out" integration model in China, characterized by high clinical utility but restricted by an "interpretability gap," underscoring the need for specialized tools and robust regulatory frameworks to safely harness AI's potential in this expanding market.
翻译:尽管人工智能在全球兽医医学领域的整合正在加速,但其在中国等主要市场的采纳动态仍未被充分描述。本文基于2025年中期对455名从业者进行的横断面调查,首次对中国兽医专业人员的人工智能认知与采纳情况进行了探索性分析。我们发现了一个显著的“采纳悖论”:尽管71.0%的受访者已将人工智能纳入工作流程,但其中44.6%的活跃用户报告对该技术熟悉度较低。与北美观察到的以行政管理为主的采纳模式不同,中国的采纳模式由从业者驱动,并集中于核心临床任务,如疾病诊断(50.1%)和处方计算(44.8%)。然而,对可靠性和准确性的担忧仍是主要障碍(54.3%),与此同时,对监管监督存在强烈共识(93.8%)。这些发现表明中国存在一种独特的“由内向外”整合模式,其特点是临床效用高,但受限于“可解释性差距”,这突显了需要专门工具和健全的监管框架,以安全利用人工智能在这一不断扩张市场中的潜力。